Search

  • HOME
  • Search
Original Article
A Comparative study of Sulbactam/Ampicillin vs Ampicillin/Amikacin in infections of the Pediatric Age Group.
Keun Soo Lee, Ha Baik Lee, Seon Ock Khang, Jung Hee Lee, Tai Yeal Choi, Choon Won Kim
Clin Exp Pediatr. 1986;29(1):1-17.   Published online January 31, 1986
Sulbactam has been shown to be an irreversible inhibitor of bacterial beta.lactamase. The spectrum of Ampicillin is extended hen it is used in combination with Sulbactam to cover Ampicillin resistant organisms. The safety and efficacy of Sulbactamj Ampicillin vs. Ampicillin/Amikacin are compared in the treatment of various disease in pediatric age group Patients are assigned randomly to receive either Sulbactam/...
Laboratory and Clinical Study of Ceftizoxime Sodium (Epocelin(R)) in Infections of the Pediatric Age Group.
Keun Soo Lee, Hahng Lee, Jeh Hoon Shin, Kook Young Meng, Dae Keun Kim, Choon Won Kim
Clin Exp Pediatr. 1984;27(7):685-701.   Published online July 31, 1984
An in-vitro sensitivity of Ceftizoxime sodium (CZX), a third generation Cephalosporin, using Epocelin® (a product of Fujisawa Pharmaceutical Central Laboratory, Japan), was studied against various bacterial strains isolated from the children with infections hospitalized on the pediatric ward of Hanyang University Hospital during the period from February, 1983 up to June, 1983. And therapeutic responses were observed in 26 pediatric...


TOPICS

Browse all articles >

ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
ABOUT
Editorial Office
Korean Pediatric Society
#1606 Seocho World Officetel, 19 Seoun-ro, Seocho-ku, Seoul 06732, Korea
Tel: +82-2-3473-7306    Fax: +82-2-3473-7307    E-mail: office@e-cep.org                

Clinical and Experimental Pediatrics is an open access journal. All articles are distributed under the terms of the Creative Commons Attribution NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/)

Copyright © 2025 by Korean Pediatric Society.      Developed in M2PI